Short- versus long-term dual antiplatelet therapy after second-generation drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials

被引:4
|
作者
Li, Hongqing [1 ]
Guo, Wenqin [1 ]
Dai, Weiran [1 ]
Li, Lang [1 ]
机构
[1] Guangxi Med Univ, Affiliated Hosp 1, Dept Cardiol, Guangxi Cardiovasc Inst, Nanning 530021, Guangxi, Peoples R China
来源
DRUG DESIGN DEVELOPMENT AND THERAPY | 2018年 / 12卷
关键词
dual antiplatelet therapy; second-generation drug-eluting stent implantation; meta-analysis; CORONARY-ARTERY-DISEASE; FOCUSED UPDATE; CLINICAL-TRIAL; DURATION; CLOPIDOGREL; EFFICACY; DISCONTINUATION; MULTICENTER; 6-MONTH; SAFETY;
D O I
10.2147/DDDT.S165435
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Background: The optimal dual antiplatelet therapy (DAPT) duration after second-generation drug-eluting stent (DES) implantation remains unclear. We aim to evaluate the efficacy and safety of short-term (<= 6 months) and long-term (>= 12 months) DAPT after second-generation DES implantation. Methods: Randomized controlled trials (RCTs) were searched in PubMed, the Cochrane Library, the Embase and ClinicalTrials.gov in the English language. The endpoints included all-cause mortality, cardiac death, non-cardiac death, myocardial infarction (MI), stent thrombosis (ST), stroke, all bleeding, and major bleeding. The effect estimate was expressed by using the hazard ratio (HR) with 95% CI and random effect models. Results: Seven RCTs with 13,571 patients were included in this study. In terms of survival endpoints, there was no significant difference in all-cause mortality (HR: 0.91; 95% CI: 0.71-1.17), cardiac death (HR: 0.93; 95% CI: 0.67-1.29), and non-cardiac death (HR: 0.89; 95% CI: 0.62-1.28) in the 2 groups. Moreover, there was no significant difference in ischemic outcomes, including MI (HR: 1.15; 95% CI: 0.91-1.45), ST (HR: 1.11; 95% CI: 0.75-1.66), and stroke (HR: 0.85; 95% CI: 0.53-1.35) in the 2 groups. In terms of bleeding endpoints, there was no significant difference in all bleeding (HR: 0.81; 95% CI: 0.64-1.04) and major bleeding (HR: 0.82; 95% CI: 0.49-1.36) in the 2 groups. The subgroup analysis showed that the proportion of patients with acute coronary syndrome was not associated with the benefit of long-term versus short-term DAPT. Conclusion: Short-term DAPT is not inferior to long-term DAPT in patients implanted with second-generation DES.
引用
收藏
页码:1815 / 1825
页数:11
相关论文
共 50 条
  • [41] Dual Antiplatelet Therapy After Drug-Eluting Stents Implantation in East Asians: A Network Meta-Analysis of Randomized Controlled Trials
    Zhong, Peng-Yu
    Shang, Yao-Sheng
    Bai, Nan
    Ma, Ying
    Niu, Ying
    Wang, Zhi-Lu
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022, 80 (02) : 216 - 225
  • [42] Duration of dual antiplatelet therapy following drug-eluting stent implantation: A systemic review and meta-analysis of randomized controlled trials with longer follow up
    Sharma, Abhishek
    Agrawal, Sahil
    Garg, Aakash
    Vallakati, Ajay
    Lavie, Carl J.
    Helft, Gerald
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2017, 90 (01) : 31 - 37
  • [43] Stent thrombosis after second generation drug-eluting stent implantation and duration of dual antiplatelet therapy
    Amano, H.
    Kadota, K.
    Otsuru, S.
    Hasegawa, D.
    Habara, S.
    Tada, T.
    Tanaka, H.
    Fuku, Y.
    Goto, T.
    Mitsudo, K.
    EUROPEAN HEART JOURNAL, 2015, 36 : 239 - 239
  • [44] Short Duration vs Standard Duration of Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention With Second-Generation Drug-Eluting Stents - A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Randomized Controlled Trials
    Wassef, Anthony W. A.
    Khafaji, Hadi
    Syed, Ishba
    Yan, Andrew T.
    Udell, Jacob A.
    Goodman, Shaun G.
    Cheema, Asim N.
    Bagai, Akshay
    JOURNAL OF INVASIVE CARDIOLOGY, 2016, 28 (12): : E203 - E210
  • [45] Meta-Analysis of Effects of Short- versus Long-term Dual Anti-Platelet Therapy after Drug-Eluting Stent Implantation in Patients with Coronary Artery Disease
    Rahman, Hammad
    Khan, Safi
    Asif, Muhammad
    Hammad, Tehseen
    Kaluski, Edo
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (13) : B324 - B325
  • [46] Short- and long-term clinical impact of tissue protrusion after second-generation drug-eluting stent implantation for acute coronary syndrome
    Suzuki, Yoriyasu
    Tsujimoto, Satoshi
    Kagase, Ai
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (18) : B128 - B128
  • [47] Duration of Dual Antiplatelet Therapy and Late Stent Thrombosis Following Percutaneous Coronary Intervention with Second-Generation Drug-Eluting Stents: A Simple Meta-Analysis of Randomized Controlled Trials
    Lin, Bei-you
    Li, Ping
    Wu, Peng
    Jiang, Ri-na
    Bundhun, Pravesh Kumar
    Ahmed, Mohamad Anis
    ADVANCES IN THERAPY, 2019, 36 (11) : 3166 - 3173
  • [48] Duration of Dual Antiplatelet Therapy and Late Stent Thrombosis Following Percutaneous Coronary Intervention with Second-Generation Drug-Eluting Stents: A Simple Meta-Analysis of Randomized Controlled Trials
    Bei-you Lin
    Ping Li
    Peng Wu
    Ri-na Jiang
    Pravesh Kumar Bundhun
    Mohamad Anis Ahmed
    Advances in Therapy, 2019, 36 : 3166 - 3173
  • [49] Short term versus long term dual antiplatelet therapy after implantation of drug eluting stent in patients with or without diabetes: systematic review and meta-analysis of individual participant data from randomised trials
    Gargiulo, Giuseppe
    Windecker, Stephan
    da Costa, Bruno R.
    Feres, Fausto
    Hong, Myeong-Ki
    Gilard, Martine
    Kim, Hyo-Soo
    Colombo, Antonio
    Bhatt, Deepak L.
    Kim, Byeong-Keuk
    Morice, Marie-Claude
    Park, Kyung Woo
    Chieffo, Alaide
    Palmerini, Tullio
    Stone, Gregg W.
    Valgimigli, Marco
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 355
  • [50] Long-term clinical outcomes of complete versus partial stent fracture after second-generation drug-eluting stent implantation
    Kim, D. -K.
    Song, Y. -S.
    Seo, G. -W.
    Song, P. -S.
    Kim, K. -H.
    Seol, S. -H.
    Seo, J. -S.
    Jin, H. -Y.
    Jang, J. -S.
    Yang, T. -H.
    Kim, D. -K.
    Kim, D. -S.
    Kim, D. -I.
    EUROPEAN HEART JOURNAL, 2016, 37 : 664 - 664